Junling Yang
- Pharmacology top 0.5%
- Pharmacological Effects of Natural Compounds 13
-
- Traditional Chinese Medicine Analysis 8
- Molecular Biology top 5%
- Ginseng Biological Effects and Applications 10
- RNA modifications and cancer 7
- Natural product bioactivities and synthesis 6
- Cancer Research top 5%
- MicroRNA in disease regulation 6
- Cancer-related molecular mechanisms research 6
- Infectious Diseases top 5%
-
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 12
- Journals
- Acta Pharmacologica Sinica (8 papers)Drug Metabolism and Disposition (5 papers)Tumor Biology (3 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Junling Yang
105 papers receiving 3.2k citations
Peers
Comparison fields: 5 of 146
- Pharmacology 523
- Complementary and alternative medicine 384
- Molecular Biology 1.6k
- Cancer Research 355
- Infectious Diseases 339
Countries citing papers authored by Junling Yang
This map shows the geographic impact of Junling Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junling Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junling Yang more than expected).
Fields of papers citing papers by Junling Yang
This network shows the impact of papers produced by Junling Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junling Yang. The network helps show where Junling Yang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Junling Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 2 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 7 | |
| 5 | 2023 | 0 | |
| 6 | 2023 | 33 | |
| 7 | 2020 | 28 | |
| 8 | 2020 | 10 | |
| 9 | 2019 | 22 | |
| 10 | 2018 | 21 | |
| 11 | 2018 | 14 | |
| 12 | 2018 | 24 | |
| 13 | 2018 | 29 | |
| 14 | 2017 | 13 | |
| 15 | 2017 | 41 | |
| 16 | 2014 | 56 | |
| 17 | 2009 | 29 | |
| 18 | Detection of PNRSV and PDV in Peach and Cherry by RT-PCR | 2005 | 3 |
| 19 | Assisted effects of lower limb orthosis on the recovery of activities of daily living and walking ability in spinal injured patients | 2005 | 1 |
| 20 | Expression of human single-chain variable fragment antibody against non-structural protein 3 of hepatitis C virus antigen in e.coli. | 2000 | 2 |
About Junling Yang
Junling Yang is a scholar working on Pharmacology, Complementary and alternative medicine, Cancer Research, Molecular Biology and Periodontics, having authored 109 papers that have together received 3.2k indexed citations. Recurring topics across this work include Pharmacological Effects of Natural Compounds (13 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (12 papers), Ginseng Biological Effects and Applications (10 papers), Traditional Chinese Medicine Analysis (8 papers), RNA modifications and cancer (7 papers), MicroRNA in disease regulation (6 papers), Natural product bioactivities and synthesis (6 papers) and Cancer-related molecular mechanisms research (6 papers). The work is most often cited by research in Pharmacology (523 citations), Complementary and alternative medicine (384 citations), Molecular Biology (1.6k citations), Cancer Research (355 citations) and Infectious Diseases (339 citations). Junling Yang has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Feifei Du, Chuan Li, F. Xu, Wei Niu, Yühong Huang, Olajide E. Olaleye, Yan Sun, Bingdi Yan, Xiumei Gao and Weiwei Jia. Their work appears in journals such as Acta Pharmacologica Sinica, Drug Metabolism and Disposition, Tumor Biology, International Journal of Biological Macromolecules and Journal of Ethnopharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.